欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
CL2A-SN-38_1279680-68-0_产品详情
1279680-68-0
  • names:

    CL2A-SN-38

  • CAS号:

    1279680-68-0

    MDL Number:
  • MF(分子式): C73H97N11O22 MW(分子量): 1480.61
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
CL2A-SN-38
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001083-250mg 250mg ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM001083-100mg 100mg >97% ¥ 0.00 ¥ 0.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1279680-68-0
Inchi
InchiKey
分子式 Formula C73H97N11O22
分子量 Molecular Weight 1480.61
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
CL2A-SN-38(CAS:1279680-68-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 CL2A-SN-38 为drug-linker conjugate,由连接桥 CL2A 和 毒性分子 SN-38 连接而成的,可用来制备抗体偶联药物
IntroductionCL2AN8 is adruginker conjugatecomposed of a potent a DNA Topoisomerase I inhibitor SN8 and a linker CL2A to make antibody drug conjugate (ADC). CL2AN8 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A is a nonclaevable complicated PEG8and triazoleontaining PABCeptidec linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond.
Application1
Application2
Application3
CL2A-SN-38 为drug-linker conjugate,由连接桥 CL2A 和 毒性分子 SN-38 连接而成的,可用来制备抗体偶联药物。CL2A-SN-38 针对人类实体瘤表现出特异性的抗肿瘤作用。SN-38 是一种有效的 DNA Topoisomerase I 抑制剂。CL2A 是一种有效的不可降解的含 PEG8-和三偶氮的 PBC-肽-mc 连接桥。CL2A 通过 pH 敏感性裂解,产生旁观者效应,并通过二硫键与抗体结合在半胱氨酸残基上。CL2A-SN-38 is adrug-linker conjugatecomposed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A is a nonclaevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Cardillo TM, et al. Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin Cancer Res. 2011 May 15;17(10):3157-69.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents